Amplia Therapeutics Limited (ASX:ATX)
Share Price and News


Company Profile:

Amplia Therapeutics Limited is based in Melbourne, Australia. It is engaged with the development of FAK (Focal Adhesion Kinase) for the treatment of diseases like cancer and fibrosis. FAK is positioning itself as a significant pick in the cancer immunology and Amplia. Some of the company’s drug candidate include- AMP945 & AMP886.



Code : ASX:ATX Healthcare Company


Amplia Therapeutics Limited (ASX:ATX)
Share Price and News


Company Profile:

Amplia Therapeutics Limited is based in Melbourne, Australia. It is engaged with the development of FAK (Focal Adhesion Kinase) for the treatment of diseases like cancer and fibrosis. FAK is positioning itself as a significant pick in the cancer immunology and Amplia. Some of the company’s drug candidate include- AMP945 & AMP886.



Code : ASX:ATX Healthcare Company